Genmab — December 2020
-
-
Spændende....:-)
-
En investors spændende tanker om $TRIL og konkurrenter i CD47.
https://drive.google.com/file/d/1izk0BFPtslVRCsui3VzElU2lTNqrA16p/view -
God morgen.
-
God morgen
-
-
AbbVie comments, search for Genmab https://seekingalpha.com/article/4392665-abbvie-abbv-management-on-evercore-isi-3rd-annual-healthconx-conference
-
-
Yup - data with cutoff 11 february 2020
-
Not all bad - leaves room for improvement
-
First Dutch hospital to administer #Daratumumab at home (in dutch) https://coevordernieuws.nl/nieuws/saxenburgh-kunnen-kankerpatienten-thuis-chemokuur-toedienen/
-
Janssen Submits Application to U.S. FDA Seeking Approval of Amivantamab for the Treatment of Patients with Metastatic Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations https://www.businesswire.com/news/home/20201203005243/en/Janssen-Submits-Application-to-U.S.-FDA-Seeking-Approval-of-Amivantamab-for-the-Treatment-of-Patients-with-Metastatic-Non-Small-Cell-Lung-Cancer-with-EGFR-Exon-20-Insertion-Mutations#.X8jVtYXlAnU.twitter
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind